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The Babraham pig is a highly inbred breed first developed in the United Kingdom
approximately 50 years ago. Previous reports indicate a very high degree of homo-
zygosity across the genome, including the major histocompatibility complex
(MHC) region, but confirmation of homozygosity at the specific MHC loci was
lacking. Using both direct sequencing and PCR-based sequence-specific typing,
we confirm that Babraham pigs are essentially homozygous at their MHC loci and
formalise their MHC haplotype as Hp-55.6. This enhances the utility of the Babra-
ham pig as a useful biomedical model for studies in which controlling for genetic
variation is important.
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Pigs are a fundamental food producing animal and important
biomedical model. The consumption of pork continues to
rise in both the developed and developing world, particularly
in Asia,1 and preventing and controlling infectious disease
remains a priority.2,3 Reduced disease burden enables
increases in farming density and outputs, improves animal
welfare and can reduce the chance of zoonotic disease trans-
mission. Healthier animals can also significantly improve
the health and livelihood of small scale and subsistence pro-
ducers. In addition, the similarities in physiology and organ
size mean that pigs are an excellent disease model with the
potential to provide organs for human transplantation.4,5 To
enable future disease, vaccine and translational research, a
more detailed understanding of the genetic variation that
underpins differential immune responses in pigs is essential.
Domesticated pigs have maintained a significant level of
genetic diversity, both within and between breeds, despite
strong selection for production traits and inbreeding.6 Inevi-
tably, this diversity correlates with significant variation at
the polymorphic immune loci. For the pig major histocom-
patibility complex (MHC, also referred to as swine leuko-
cyte antigen [SLA]), there are currently 238 MHC class I
alleles and 223 MHC class II alleles described for Sus scrofa
in the Immuno-Polymorphism Database (IPD)-MHC data-
base (http://www.ebi.ac.uk/ipd/mhc/group/SLA).7 The anti-
body lambda locus also appears to be highly polymorphic,
even among commercial pigs with a similar genetic
background,8 and the T-cell loci appear variable in gene con-
tent, at least between breeds (Schwartz, J.C., T. Connelley,
and J.A. Hammond, unpublished). This diversity is
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problematic for infectious disease research and quantitative
trait mapping studies in which complex and uncontrolled
genetic variation may confound results and reduce statistical
power. Immunogenetic variation also presents significant
problems for preclinical studies with the pig as a model and
future efforts to enable xenotransplantation. For example,
porcine endogenous retroviruses (PERVs), encoded in the
pig genome, have impeded organ xenotransplantation as
they pose a risk if passed to humans. These elements have
recently been removed using genome editing in an outbred
pig.9 The same work on a large inbred pig (that can produce
suitably sized organs) would decrease the possibility of addi-
tional uncharacterized PERVs that are likely in outbred
populations. Furthermore, having a defined MHC allows
one to predict tolerance and associated clinical interventions.
For instance, the power of the inbred Babraham pig model
has recently been shown in a genome-wide analysis which
identified minor histocompatibility antigens involved in cor-
neal transplant rejection.10 This work was only possible
using individuals with a controlled genetic background and a
defined MHC region in order to facilitate matching and mis-
matching of histocompatibility loci. Large inbred pig models
are therefore fundamentally important scientific resources.
In the United Kingdom, and likely the whole world, the
Babraham pig is the only extant example of a large inbred
pig breed. While there are several MHC inbred miniature
pig breeds that have been developed, including the NIH and
Yucatan miniature pigs,11,12 these are less representative of
commercial breeds. As a consequence, the Babraham pig
has great potential to play an important role in studying
infectious diseases in pigs and as a preclinical model for
human disease. Babraham pigs were derived from a Large
White commercial background by Dr Richard Binns at the
Babraham Institute (UK) during the 1970s.13 Multiple skin
grafts were performed across potential parents and selective
breeding was carried out between those individuals in which
least cross-rejection was observed. This was continued for
five generations, rejecting defective individuals and those
with residual skin graft rejection, and which produced indi-
viduals that tolerated skin grafts. This tolerance indicated
functional homozygosity at least for the MHC antigens and
probably also for a high proportion of minor histocompati-
bility loci. After 20 generations, a restriction fragment length
polymorphism study showed a level of inbreeding homozy-
gosity comparable to inbred strains of mice.13 During the
period from this 1999 study until 2016, there were approxi-
mately 15 generations and recovery from a bottleneck of
nine sows and three boars with the current population origi-
nating from five sows and one boar (animal records from
The Pirbright Institute). At this point, single nucleotide poly-
morphism (SNP) analysis using the Illumina PorcineSNP60
chip suggested approximately 85% homozygosity across the
Babraham genome, based on 59 852 genotyped SNPs.10
Other animals with the same level of inbreeding and homo-
zygosity are not available for large veterinary species.
The SNP chip analysis by Nicholls et al10 indicated com-
plete homozygosity across the MHC region of chromosome
7. However, measuring MHC variation using commercial
SNP assays is not always accurate as much of the variation
over polymorphic loci falls below the minimum minor allele
frequency to be included in the assay. In addition, structurally
variable haplotypes often confound the mapping of second-
generation sequencing technologies that produce relatively
short reads used to design the SNP chip. Indeed, using
SNPchimp14 to search the Illumina 60 k SNP array showed
only two SNPs present in the vicinity of the classical MHC
class I loci (ie, within the interval of Sscrofa10.2, chr
7:24 600 000-24 765 000). Confirming that the Babraham
MHC is homozygous would add significant value to this ani-
mal line as both a veterinary and biomedical model. We
therefore used two different typing methods to confirm MHC
homozygosity and formalise the Babraham MHC haplotype.
The genes targeted for cDNA sequencing were the clas-
sical MHC class I genes SLA-1, SLA-2 and SLA-3, the non-
classical class I genes SLA-6, SLA-7 and SLA-8, and the class
II genes SLA-DQA, SLA-DQB1 and SLA-DRB1. All known
SLA alleles within the IPD-MHC database were downloaded
and used for oligonucleotide primer design (Table 1). Total
RNA was extracted from peripheral blood mononuclear cells
derived from six animals (as distantly related as possible and
including non-breeding individuals) using TRIzol (Thermo
Fisher Scientific, Loughborough, United Kingdom) follow-
ing manufacturer's instructions. Complementary DNA
(cDNA) was generated using the Superscript III reverse tran-
scriptase kit (Thermo Fisher Scientific) following manufac-
turer's instructions. Polymerase chain reaction (PCR)
amplicons were generated from this cDNA, ligated into
pGEM-T Easy vector (Promega, Madison, Wisconsin), and
transformed into NEB 5-alpha chemically-competent
Escherichia coli (New England Biolabs, Ipswich, Massachu-
setts). Approximately 584 individual clones were selected
by positive colony PCR result and submitted to Source Bio-
Science (UK) for sequencing. Sanger chain-termination
sequencing was performed using either of the vector-specific
T7 (forward) or SP6 (reverse) primers. The chromatograms
from the individual sequencing reads were then compared
with the known alleles within the IPD-MHC database.
To further confirm SLA homozygosity in the Babraham
pigs, genotyping of SLA-1, SLA-2, SLA-3, DRB1, DQB1 and
DQA was performed on the genomic DNA from 22 animals
(including the six animals used for cDNA analysis) using
PCR-based assays with sequence-specific typing primers
(PCR-SSP) as previously described.15,16 The typing primer
panel has since been modified to accommodate for the
increasing number of SLA alleles and allele groups (details
not shown).
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Both SSP typing and sequencing methods confirmed
homozygosity at the SLA-1, SLA-2, SLA-DQA, SLA-DRB1
and SLA-DQB1 loci (Table 2). The sequenced region of
SLA-DQB1, containing the majority of both beta domains,
could not differentiate between alleles SLA-DQB1*08:01
and SLA-DQB1*08:02, which differ from each other at two
nucleotide positions outside of the sequenced region (ie, at
positions +52 and +606). This gene was nevertheless identi-
cal over the sequenced region in all animals based on reads
from eight clones per animal. Only three sequencing reads
from two animals were recovered for SLA-3. One of these
reads corresponded with SLA-3*04:02 and the remaining
two reads corresponded with SLA-3*04:03, indicating that at
least one of the six animals is a heterozygote at this locus.
These two alleles differ only in the alpha-3 domain, by both
a 12-bp insertion in SLA-3*04:03 and a single non-
synonymous mutation 9 bp upstream of the insertion. How-
ever, it is uncertain what, if any, influence these differences
have on peptide-binding and receptor interactions, especially
as this region is distal from the peptide-binding regions of
the alpha-1 and alpha-2 domains. The paucity of SLA-3
reads is likely due to the co-amplification of SLA-3 cDNA
with SLA-1 and SLA-2, both of which are considered more
highly expressed.17,18 The haplotype that corresponds to the
genotype SLA-1*14:02-SLA-3*04:03-SLA-2*11:04-DRB1*0
5:01-DQB1*08:01 has been previously designated by the
ISAG/IUIS-VIC SLA Nomenclature Committee Hp-55.6.
The class I haplotype Hp-55.0 was originally described in
the ESK-4 cell line,19 while the class II haplotype Hp-0.6
has been detected in several pig breeds including Yucatan,20
Austrian Pietrain,21 Chinese Bama miniature pigs,22 as well
as the SK-RST cell line.19
Sequencing reads were additionally obtained for the non-
classical MHC class I genes (SLA-6, SLA-7, and SLA-8) due
to broad primer specificity. A total of six identical reads
from three animals were identified for SLA-6, all of which
contained the intron between the first two alpha domains,
and thus originated from either unspliced mRNA or contami-
nating genomic DNA. Despite this, both exons were in
frame and putatively functional. All of these reads also dif-
fered by at least 4 bp from the nine known SLA-6 alleles in
IPD-MHC, with five alleles being equally close (SLA-
6*01:01, SLA-6*03:01, SLA-6*04:01, SLA-6*05:01 and
SLA-6*06:01). Reads specific for SLA-7 (n = 1) and SLA-8
(n = 8, from four animals) were also detected, likely due to
the degenerate nature of the SLA-6 primers used for cDNA
amplification. Only three alleles of SLA-7 are currently
described within the IPD-MHC database, and the closest of
these, SLA-7*01:01, differs by 2 bp to the single read
sequenced from the Babraham samples. For SLA-8, all of the
sequencing reads were identical to each other and were also
exact matches for known alleles SLA-8*01:01, SLA-8*04:01
and SLA-8*05:01. As the sequenced reads did not span the
entire transcript, it could not be ascertained which, if any, of
TABLE 1 Oligonucleotide primers used for amplification of SLA genes
Gene Orientation Sequence (50-) CDNA position Domain
SLA-1,-2, -3, -7, and -8 Sense GACACGCAGTTCGTGHGGTTC 153-163 α1
SLA-6 Sense AGGACCCGCGTCTGGAGAAG 150 α1
SLA-1,-2,-3,-6, -7, and -8 Anti-sense CTGGAAGGTCCCATCCCCTG 789-799 α3
SLA-1,-2,-3, -6, and -7 Anti-sense GCTGCACMTGGCAGGTGTAGC 851-861 α3
SLA-DQA Sense GAGCGCCTGTGGAGGTGAAG 54 Leader
SLA-DQA Sense GACCATGTTGCCTCCTATGGC 85 α1
SLA-DQA Anti-sense CAGATGAGGGTGTTGGGCTGAC 398 α2
SLA-DQA Anti-sense GACAGAGTGCCCGTTCTTCAAC 462 α2
SLA-DQB1 Sense GAGACTCTCCACAGGATTTCGTG 98 β1
SLA-DQB1 Anti-sense ACTGTAGGTTGCACTCGCCG 395 β2
SLA-DRB1 Sense GGGACAYCSCACMGCATTTC 89 β1
SLA-DRB1 Sense GAGTGYCRTTTCTTCAVYGGGAC 127 β1
SLA-DRB1 Anti-sense CAGAGCAGACCAGGAGGTTGTG 421 β2
SLA-DRB1 Anti-sense GGTCCAGTCTCCATTAGGGATC 552 β2
Abbreviation: SLA, swine leukocyte antigen.
TABLE 2 Classical MHC class I and class II genotypes of inbred Babraham pigs
SLA-1 SLA-2 SLA-3 DRB1 DQA DQB1
Sequencing *14:02a *11:04b *04:03c/*04:02 *05:01 *01:03 *08:01 or *08:02
SSP typing *14:02 *11:04 *04:XX *05:XX *01:XX *08:XX
Abbreviations: MHC, major histocompatibility complex; SLA, swine leukocyte antigen; SSP, sequence-specific typing primers.
a Previously known as SLA-1*es11.
b Previously known as SLA-2*es22.
c Previously known as SLA-3*04es32.
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these alleles correspond to the Babraham SLA-8. Thus, the
sequencing results suggested that the Babraham animals
were identical to each other for at least the SLA-6 and SLA-8
non-classical MHC class I loci, while only a single read was
obtained for SLA-7.
For inclusion into the IPD-MHC database, the
Babraham-derived alleles presented here have been depos-
ited into GenBank (accessions: MH107868—MH107877).
This study shows that the inbred Babraham pigs are func-
tionally MHC homozygous. Taken together with the high
level of inbreeding as measured by SNPs over the entire
genome,10 this confirms the Babraham pig as a very valuable
model for swine and human disease research, as well in
wider biomedical applications. This value can only increase
as our ability to edit mammalian genomes and produce
gene-edited animals improves.
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